TELMIECHEK-H 10

About

TELMIECHEK-H combines telmisartan, an angiotensin II receptor blocker (ARB), with hydrochlorothiazide, a thiazide diuretic, to provide comprehensive treatment for essential hypertension. Telmisartan works by blocking the effects of angiotensin II, a potent vasoconstrictor, leading to relaxation of blood vessels and a decrease in blood pressure. Hydrochlorothiazide complements this action by increasing the excretion of sodium and water from the body, further reducing blood volume and pressure. This synergistic combination is particularly effective for patients whose blood pressure is not adequately controlled by a single agent, offering a robust approach to managing high blood pressure and mitigating associated cardiovascular risks. The dual mechanism ensures sustained blood pressure control throughout the day.

Uses

• Management of essential hypertension.
• Treatment for patients requiring more than one antihypertensive agent.
• Reduction of overall cardiovascular risk.
• Control of fluid retention associated with elevated blood pressure.

Directions For Use

Administer one tablet orally once daily, with or without food, as advised by your healthcare professional.

Benefits

• Achieves significant and consistent blood pressure reduction.
• Utilizes two distinct mechanisms for enhanced efficacy.
• Helps prevent serious cardiovascular events like stroke.
• Offers the convenience of a single daily dose.
• Assists in fluid balance regulation.
• Potentially improves adherence to treatment regimens.

Side Effects

• Lightheadedness
• Drowsiness
• Headache
• Stomach upset
• Loose stools
• Respiratory tract infections
• Back discomfort
• Muscle stiffness
• Low blood pressure
• Electrolyte imbalances (e.g., low potassium)
• Elevated blood sugar
• Increased cholesterol levels

Safety Measures

• Alcohol - Concurrent use of alcohol may intensify the blood pressure-lowering effects, potentially causing severe dizziness or fainting. Limit alcohol intake.
• Pregnancy - This medication is contraindicated during the second and third trimesters due to significant risks of fetal injury or death. Avoid use during pregnancy.
• Breastfeeding - Both active ingredients pass into breast milk. It is generally not recommended for use by breastfeeding mothers.
• Liver - Exercise caution in patients with severe liver impairment or progressive liver disease, as it may worsen fluid and electrolyte disturbances.
• Kidney - Contraindicated in individuals with anuria or severe kidney dysfunction. Dose adjustments are necessary for moderate impairment.
• Lung - Generally safe for individuals with lung conditions, but caution is advised in those with a history of allergy to sulfonamide-derived drugs (due to HCTZ).

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.